Kamada (KMDA) Interest Coverage Ratio: History & Chart

Kamada Ltd.(KMDA)

Drug Manufacturers - Specialty & Generic · Rehovot, HM

$7.90-0.10 (-1.30%)

Delayed quote: Oct 6, 2026, 10:44 AM EDT

About Kamada Ltd.

Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipients, WINRHO SDF for immune thrombocytopenic purpura and Rhesus (Rh) isoimmunization, HEPAGAM B for hepatitis B recurrence prevention following liver transplants and for post-exposure prophylaxis, VARIZIG for post-exposure chickenpox prophylaxis, and GLASSIA for intravenous alpha-1 antitrypsin deficiency (AATD). Kamada also produces KamRho (D) for the prophylaxis of hemolytic disease of newborns and immune thrombocytopenic purpura, along with a specific antiserum for Vipera palaestinae and Echis coloratus snake bites. Additionally, the company distributes a wide array of third-party pharmaceutical products, encompassing treatments like BRAMITOB for chronic pulmonary infections, FOSTER for asthma, PROVOCHOLINE for diagnosing bronchial airway hyperactivity, and specialized therapies such as IVIG for immunodeficiency, VARITECT for chickenpox and zoster herpes, and various factors for hemophilia A and B, among numerous others for conditions like hepatitis B, cytomegalovirus, angioedema, Japanese encephalitis, and prostate cancer. Kamada markets its offerings in the United States through strategic partners and internationally via a network of distributors. The company maintains significant collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. Established in 1990, Kamada Ltd. is headquartered in Rehovot, Israel.

Rehovot, HM

462 employees

www.kamada.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Amir London

View full financials

KMDA Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

30.36x

INTEREST COVERAGE RATIO AVG TTM

29.73x

INTEREST COVERAGE RATIO AVG 3Y

27.41x

INTEREST COVERAGE RATIO AVG 5Y

17.13x

INTEREST COVERAGE RATIO AVG 10Y

28.25x

INTEREST COVERAGE RATIO AVG 15Y

15.83x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+2.11%

CURRENT VS 3Y AVG

+10.76%

CURRENT VS 5Y AVG

+77.23%

CURRENT VS 10Y AVG

+7.49%

CURRENT VS 15Y AVG

+91.78%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-4.99x

median of 387 covered companies

CURRENT VS SECTOR MEDIAN

+708.42%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Kamada Ltd. (KMDA)	$455.58M	30.36x	29.73x	27.41x	17.13x
NRC Health (NRC)vs ›	$461.10M	4.74x	9.15x	25.82x	26.16x
Cerus Corporation (CERS)vs ›	$466.53M	-1.04x	N/A	N/A	N/A
Contineum Therapeutics, Inc. (CTNM)vs ›	$466.50M	N/A	N/A	N/A	N/A
DiaMedica Therapeutics Inc. (DMAC)vs ›	$440.77M	N/A	N/A	N/A	N/A
Arvinas, Inc. (ARVN)vs ›	$471.33M	N/A	N/A	N/A	N/A
Bright Minds Biosciences Inc. (DRUG)vs ›	$470.08M	N/A	N/A	N/A	N/A
Evolus, Inc. (EOLS)vs ›	$473.33M	-1.91x	N/A	N/A	N/A
NeuroPace, Inc. (NPCE)vs ›	$439.24M	-2.19x	N/A	N/A	N/A
NeoGenomics, Inc. (NEO)vs ›	$436.69M	-17.61x	2.56x	1.47x	1.63x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Kamada Ltd. (KMDA)

$455.58M

30.36x

29.73x

27.41x

17.13x

NRC Health (NRC)vs ›

$461.10M

4.74x

9.15x

25.82x

26.16x

Cerus Corporation (CERS)vs ›

$466.53M

-1.04x

N/A

Contineum Therapeutics, Inc. (CTNM)vs ›

$466.50M

N/A

DiaMedica Therapeutics Inc. (DMAC)vs ›

$440.77M

N/A

Arvinas, Inc. (ARVN)vs ›

$471.33M

N/A

Bright Minds Biosciences Inc. (DRUG)vs ›

$470.08M

N/A

Evolus, Inc. (EOLS)vs ›

$473.33M

-1.91x

N/A

NeuroPace, Inc. (NPCE)vs ›

$439.24M

-2.19x

N/A

NeoGenomics, Inc. (NEO)vs ›

$436.69M

-17.61x

2.56x

1.47x

1.63x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Kamada Ltd. (KMDA)?

The interest coverage ratio for KMDA stock is 30.36x.

Is Kamada Ltd.'s interest coverage ratio high or low?

The interest coverage ratio of 30.36x is 77% above its 5-year average of 17.13x, near the high end of its 5-year range (-13.18x–40.60x).

What is the TTM average interest coverage ratio for Kamada Ltd. (KMDA)?

The TTM average interest coverage ratio for KMDA stock is 29.73x.

What is the 3Y average interest coverage ratio for Kamada Ltd. (KMDA)?

The 3Y average interest coverage ratio for KMDA stock is 27.41x.

What is the 5Y average interest coverage ratio for Kamada Ltd. (KMDA)?

The 5Y average interest coverage ratio for KMDA stock is 17.13x.

What is the 10Y average interest coverage ratio for Kamada Ltd. (KMDA)?

The 10Y average interest coverage ratio for KMDA stock is 28.25x.

What is the 15Y average interest coverage ratio for Kamada Ltd. (KMDA)?

The 15Y average interest coverage ratio for KMDA stock is 15.83x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	25.78x
2026-03-31	36.98x
2025-12-31	13.71x
2025-09-30	35.37x
2025-06-30	36.83x
2025-03-31	40.60x
2024-12-31	26.87x
2024-09-30	31.70x
2024-06-30	38.90x
2024-03-31	25.40x
2023-09-30	10.81x
2023-06-30	5.99x
2023-03-31	0.58x
2022-12-31	12.14x
2022-09-30	12.14x
2022-06-30	-12.89x
2022-03-31	1.27x
2021-12-31	-3.00x
2021-09-30	-13.18x
2021-06-30	16.60x
2021-03-31	44.60x
2020-12-31	42.73x
2020-09-30	112.51x
2020-06-30	68.53x
2020-03-31	62.99x
2019-12-31	72.17x
2019-09-30	83.78x
2019-06-30	88.79x
2019-03-31	73.37x
2018-12-31	357.77x
2018-09-30	-64.72x
2018-06-30	92.34x
2018-03-31	7.82x
2017-12-31	57.54x
2017-09-30	-22.43x
2017-06-30	386.46x
2017-03-31	-161.35x
2016-12-31	-94.70x
2016-09-30	-26.13x
2016-06-30	-19.67x
2016-03-31	-53.46x
2015-12-31	7.21x
2015-09-30	-12.05x
2015-06-30	-9.75x
2015-03-31	-24.06x
2014-12-31	2.95x
2014-09-30	-3.29x
2014-06-30	-10.71x
2014-03-31	-4.02x
2013-12-31	3.53x
2013-09-30	1.03x
2013-06-30	2.38x
2013-03-31	-1.53x
2012-12-31	4.42x
2012-09-30	1.64x
2012-06-30	-1.25x

DATE

INTEREST COVERAGE RATIO

2026-06-30

25.78x

2026-03-31

36.98x

2025-12-31

13.71x

2025-09-30

35.37x

2025-06-30

36.83x

2025-03-31

40.60x

2024-12-31

26.87x

2024-09-30

31.70x

2024-06-30

38.90x

2024-03-31

25.40x

2023-09-30

10.81x

2023-06-30

5.99x

2023-03-31

0.58x

2022-12-31

12.14x

2022-09-30

12.14x

2022-06-30

-12.89x

2022-03-31

1.27x

2021-12-31

-3.00x

2021-09-30

-13.18x

2021-06-30

16.60x

2021-03-31

44.60x

2020-12-31

42.73x

2020-09-30

112.51x

2020-06-30

68.53x

2020-03-31

62.99x

2019-12-31

72.17x

2019-09-30

83.78x

2019-06-30

88.79x

2019-03-31

73.37x

2018-12-31

357.77x

2018-09-30

-64.72x

2018-06-30

92.34x

2018-03-31

7.82x

2017-12-31

57.54x

2017-09-30

-22.43x

2017-06-30

386.46x

2017-03-31

-161.35x

2016-12-31

-94.70x

2016-09-30

-26.13x

2016-06-30

-19.67x

2016-03-31

-53.46x

2015-12-31

7.21x

2015-09-30

-12.05x

2015-06-30

-9.75x

2015-03-31

-24.06x

2014-12-31

2.95x

2014-09-30

-3.29x

2014-06-30

-10.71x

2014-03-31

-4.02x

2013-12-31

3.53x

2013-09-30

1.03x

2013-06-30

2.38x

2013-03-31

-1.53x

2012-12-31

4.42x

2012-09-30

1.64x

2012-06-30

-1.25x

Interest Coverage Ratio: 30.36x

KMDA Interest Coverage Ratio

KMDA Average Interest Coverage Ratio Chart

KMDA Current vs Average Interest Coverage Ratio Chart

KMDA Interest Coverage Ratio Metrics

KMDA Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

KMDA Interest Coverage Ratio History

Related Metrics